Tag: WHO

  • This is Why Pfizer Just Popped, As We Expected

    This is Why Pfizer Just Popped, As We Expected

    Pfizer is pushing to higher highs. In fact, as we noted on November 2, “After finding support around $41, the vaccine stock bolted to nearly $46, and could test $47, even $50, near-term.  All after the company raised its full-year sales forecast to $36 billion, as it signed deals for booster doses.  The stock could…